Antiviral Drugs Market by Drug Class (Polymerase Inhibitors, Protease Inhibitors), By Disease Indication (Hepatitis, Human Immuno Deficiency Virus {HIV}, Influenza and others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2024
- Report ID: 97163
- Number of Pages: 380
- Format:
-
keyboard_arrow_up
-
-
- Gilead Sciences Inc.
- AbbVie, Inc.
- GlaxoSmithKline
- Merck& C.O., Inc.
- Jannssen Pharmaceuticals, Inc.
- Bristol- Meyrs Squibb Company
- Mylan N. V.
- Novartis AG Company Profile
- AstraZeneca Plc Company Profile
- Pfizer Inc Company Profile
- Cipla Inc.
- Johnson & Johnson Services, Inc.
- Aurobindo Pharma
- Merck MRK
- Reddy Laboratories Limited
- Hoffmann-La Roche Ltd.
- Altesa Biosciences Inc.
- Other Key Players
- settingsSettings
Our Clients
- 97163
- Oct 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
